<code id='1826280852'></code><style id='1826280852'></style>
    • <acronym id='1826280852'></acronym>
      <center id='1826280852'><center id='1826280852'><tfoot id='1826280852'></tfoot></center><abbr id='1826280852'><dir id='1826280852'><tfoot id='1826280852'></tfoot><noframes id='1826280852'>

    • <optgroup id='1826280852'><strike id='1826280852'><sup id='1826280852'></sup></strike><code id='1826280852'></code></optgroup>
        1. <b id='1826280852'><label id='1826280852'><select id='1826280852'><dt id='1826280852'><span id='1826280852'></span></dt></select></label></b><u id='1826280852'></u>
          <i id='1826280852'><strike id='1826280852'><tt id='1826280852'><pre id='1826280852'></pre></tt></strike></i>

          explore

          explore

          author:Wikipedia    Page View:52
          Ed Silverman on the Breakthrough Summit stage in 2023.
          STAT's Ed Silverman on stage at the STAT Breakthrough Summit in 2023. Sarah Gonzalez for STAT

          In 2023, STAT launched a brand-new home for our subscribers to connect with each other and with their favorite STAT journalists. On STAT+ Connect, you can find job postings; comment on STAT articles (since we have closed comments on article pages); discuss industry events with other people who work in biotech, pharma, public health advocacy, PR, and more; read insights and exclusive material posted by STAT reporters and editors; and watch events, including live interviews and text-based Ask Me Anything chats.

          Last week, Ed Silverman, AKA Pharmalot, hosted an AMA titled “Stump Pharmalot.” During the AMA, Ed discussed gene therapy, his proudest career moments, what he took in high school instead of chemistry, coffee (or, as he calls it, “cups of stimulation”), and more.

          advertisement

          Below, you can find a lightly edited transcript of the conversation.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          FDA official pushes for dedicated emerging pathogens team
          FDA official pushes for dedicated emerging pathogens team

          PeterMarks,directoroftheFDA'sCenterforBiologicsEvaluationandResearchGregNash/PoolviaAPWASHINGTON—Ato

          read more
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more

          Study suggests Covid rebound is far more common with Paxlovid than without

          AdobeAsmallandpreliminarystudypublishedMondayseemstoindicatethatpatientsreceivingthedrugPaxlovidaref